Mirabegron (beta3-adrenoceptor agonist)

DRUG2 trials

Sponsors

Başakşehir Çam & Sakura City Hospital, Bagcilar Training and Research Hospital

Conditions

Ejaculation AbnormalOveractive Bladder (OAB)Premature (Early) Ejaculation

Unknown Phase

Effect of Antimuscarinic Treatment on Premature Ejaculation Severity in Men With Overactive Bladder: a Prospective Comparison With Mirabegron

CompletedNCT07736560

Başakşehir Çam & Sakura City HospitalEjaculation Abnormal, Overactive Bladder (OAB), Premature (Early) Ejaculation

Start: 2026-01-15End: 2026-06-30Updated: 2026-08-13

Predictive Value of Inflammatory Biomarkers for Mirabegron Response in Women With Overactive Bladder

Not yet recruitingNCT07773532

Bagcilar Training and Research HospitalOveractive Bladder (OAB)

Start: 2026-10-01End: 2027-11-01Target: 115Updated: 2026-08-19